Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Prognosis"" wg kryterium: Temat


Starter badań:

Tytuł:
Effect modification in a clinical trial should be assessed through interaction terms, not prognostic modelling.
Autorzy:
Roepke RML; Trauma and Acute Care Surgery ICU, Department of Surgery, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.; Intensive Care Unit, A.C. Camargo Cancer Center, São Paulo, SP, Brazil.
Mendes PV; Medical ICU, Department of Medicine, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.
Cardozo Junior LCM; Medical ICU, Department of Medicine, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.
Park M; Medical ICU, Department of Medicine, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.
Besen BAMP; Intensive Care Unit, A.C. Camargo Cancer Center, São Paulo, SP, Brazil. .; Medical ICU, Department of Medicine, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, Av. Dr. Enéas Carvalho de Aguiar, 255, 11th Floor, Room 11083, São Paulo, SP, 05403-000, Brazil. .
Pokaż więcej
Źródło:
Intensive care medicine [Intensive Care Med] 2022 Aug; Vol. 48 (8), pp. 1122-1124. Date of Electronic Publication: 2022 May 27.
Typ publikacji:
Letter; Comment
MeSH Terms:
Prognosis*
Humans
Opinia redakcyjna
Tytuł:
Prognostic analysis of hidradenocarcinoma: a SEER-based observational study.
Autorzy:
Gao T; Department of Dermatology, Changzhou Geriatric Hospital Affiliated to Soochow University, Changzhou No.7 People's Hospital, Changzhou, China.
Pan S; Department of Dermatology, Changzhou Geriatric Hospital Affiliated to Soochow University, Changzhou No.7 People's Hospital, Changzhou, China.
Li M; Department of Dermatology, Changzhou Geriatric Hospital Affiliated to Soochow University, Changzhou No.7 People's Hospital, Changzhou, China.
Su R; Department of Neurology, Changzhou Geriatric Hospital Affiliated to Soochow University, Changzhou No.7 People's Hospital, Changzhou, China.
Pokaż więcej
Źródło:
Annals of medicine [Ann Med] 2022 Dec; Vol. 54 (1), pp. 454-463.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Prognosis*
Humans ; SEER Program ; Survival Analysis ; Survival Rate
Czasopismo naukowe
Tytuł:
GRADE concept paper 2: Concepts for judging certainty on the calibration of prognostic models in a body of validation studies.
Autorzy:
Foroutan F; Ted Rogers Centre for Heart Research, Peter Munk Cardiac Centre, Toronto, Ontario, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada. Electronic address: .
Guyatt G; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada.
Trivella M; Ted Rogers Centre for Heart Research, Peter Munk Cardiac Centre, Toronto, Ontario, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada; Division of Nephrology, Department of Medicine, London Health Sciences Centre, London, UK; NK: Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Evidence-based Oncology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; School of Medicine, Keele University, Keele, United Kingdom.
Kreuzberger N; NK: Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Skoetz N; NK: Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Evidence-based Oncology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Riley RD; School of Medicine, Keele University, Keele, United Kingdom.
Roshanov PS; Division of Nephrology, Department of Medicine, London Health Sciences Centre, London, UK.
Alba AC; Ted Rogers Centre for Heart Research, Peter Munk Cardiac Centre, Toronto, Ontario, Canada.
Sekercioglu N; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada.
Canelo-Aybar C; CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; Iberoamerican Cochrane Centre - Department of Clinical Epidemiology and Public Health, Biomedical Research Institute Sant Pau (IIB Sant Pau), Sant Antonio María Claret 167, 08025 Barcelona, Spain.
Munn Z; Ted Rogers Centre for Heart Research, Peter Munk Cardiac Centre, Toronto, Ontario, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada; Division of Nephrology, Department of Medicine, London Health Sciences Centre, London, UK; NK: Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Evidence-based Oncology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; School of Medicine, Keele University, Keele, United Kingdom.
Brignardello-Petersen R; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada.
Schünemann HJ; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada.
Iorio A; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamitlon, Canada.
Pokaż więcej
Źródło:
Journal of clinical epidemiology [J Clin Epidemiol] 2022 Mar; Vol. 143, pp. 202-211. Date of Electronic Publication: 2021 Nov 18.
Typ publikacji:
Journal Article
MeSH Terms:
Prognosis*
Calibration ; Forecasting ; Humans ; Probability
Czasopismo naukowe
Tytuł:
Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial.
Autorzy:
Delahunt B; Department of Pathology and Molecular Medicine and Health Sciences, University of Otago, and Southern Community Laboratory, Wellington, New Zealand. Electronic address: .
Steigler A; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia.
Atkinson C; St Georges Cancer Care Centre, Christchurch, New Zealand.
Christie D; Genesis Care, Tugun, Qld, Australia.
Duchesne G; Peter MacCallum Cancer Centre and University of Melbourne, Vic, Australia.
Egevad L; Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden.
Joseph D; Sir Charles Gairdner Hospital, Perth, WA, Australia.
Kenwright DN; Department of Pathology and Molecular Medicine and Health Sciences, University of Otago, and Southern Community Laboratory, Wellington, New Zealand.
Matthews J; Auckland City Hospital, Auckland, New Zealand.
Murray JD; Department of Pathology and Molecular Medicine and Health Sciences, University of Otago, and Southern Community Laboratory, Wellington, New Zealand.
Oldmeadow C; Hunter Medical Research Institute, Newcastle, NSW, Australia.
Samaratunga H; Aquesta Uropathology and University of Queensland, Brisbane, Qld, Australia.
Spry NA; Genesis Care, Perth, WA, Australia.
Thunders MC; Department of Pathology and Molecular Medicine and Health Sciences, University of Otago, and Southern Community Laboratory, Wellington, New Zealand.
Hondermarck H; Hunter Medical Research Institute, Newcastle, NSW, Australia; School of Biomedical Sciences and Pharmacy, University of Newcastle, NSW, Australia.
Denham JW; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia.
Pokaż więcej
Źródło:
Pathology [Pathology] 2022 Feb; Vol. 54 (1), pp. 49-54. Date of Electronic Publication: 2021 Dec 24.
Typ publikacji:
Journal Article
MeSH Terms:
Prognosis*
Adenocarcinoma/*pathology
Prostatic Neoplasms/*pathology
Biopsy, Large-Core Needle ; Humans ; Male ; Neoplasm Grading/methods ; Prostate/pathology ; Prostatectomy ; Retrospective Studies
Czasopismo naukowe
Tytuł:
The prognostic significance of pleomorphism in gastrointestinal stromal tumours.
Autorzy:
Isidro RA; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Hornick JL; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2022 Feb; Vol. 80 (3), pp. 598-603. Date of Electronic Publication: 2021 Nov 25.
Typ publikacji:
Journal Article
MeSH Terms:
Prognosis*
Biomarkers, Tumor/*genetics
Gastrointestinal Stromal Tumors/*genetics
Intestine, Small/*pathology
Mutation/*genetics
Stomach Neoplasms/*pathology
Female ; Humans ; Immunohistochemistry ; Longitudinal Studies ; Male ; Middle Aged
Czasopismo naukowe
Tytuł:
Probing patterns for prognostic potential.
Autorzy:
Levine SM; Department of Psychology, LMU Munich, Leopoldstraße 13, 80802, Munich, Germany. .; NeuroImaging Core Unit Munich (NICUM), University Hospital LMU, Nußbaumstraße 7, 80336, Munich, Germany. .
Pokaż więcej
Źródło:
Translational psychiatry [Transl Psychiatry] 2022 Apr 21; Vol. 12 (1), pp. 167. Date of Electronic Publication: 2022 Apr 21.
Typ publikacji:
Letter; Comment
MeSH Terms:
Prognosis*
Opinia redakcyjna
Tytuł:
Volumetric Splenomegaly in Patients With Polycythemia Vera.
Autorzy:
Lee MW; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Yeon SH; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Ryu H; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Song IC; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Lee HJ; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Yun HJ; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Kim SY; Department of Laboratory Medicine, Chungnam National University College of Medicine, Daejeon, Korea.
Lee JE; Department of Radiology, Chungnam National University College of Medicine, Daejeon, Korea.
Shin KS; Department of Radiology, Chungnam National University College of Medicine, Daejeon, Korea.
Jo DY; Division of Hematology/Oncology, Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea. .
Pokaż więcej
Źródło:
Journal of Korean medical science [J Korean Med Sci] 2022 Mar 21; Vol. 37 (11), pp. e87. Date of Electronic Publication: 2022 Mar 21.
Typ publikacji:
Journal Article
MeSH Terms:
Predictive Value of Tests*
Prognosis*
Polycythemia Vera/*complications
Splenomegaly/*diagnosis
Splenomegaly/*etiology
Splenomegaly/*physiopathology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Republic of Korea ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Tytuł:
A Novel Pyroptosis-Related Prognostic Signature for Risk Stratification and Clinical Prognosis in Clear Cell Renal Cell Carcinoma.
Autorzy:
Pan XQ; Department of Traditional Chinese Medicine, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Huang W; Department of Nephrology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Jin LW; Department of Nephrology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Lin HZ; Department of Traditional Chinese Medicine, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Xu XY; Department of Nephrology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Pokaż więcej
Źródło:
Disease markers [Dis Markers] 2022 Mar 09; Vol. 2022, pp. 8093837. Date of Electronic Publication: 2022 Mar 09 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression Profiling*
Prognosis*
Biomarkers, Tumor/*genetics
Carcinoma, Renal Cell/*genetics
Kidney Neoplasms/*genetics
Pyroptosis/*genetics
Computational Biology ; Databases, Genetic ; Female ; Humans ; Male ; Middle Aged ; Risk Assessment ; Risk Factors ; Transcriptome ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Identification of IL20RB as a Novel Prognostic and Therapeutic Biomarker in Clear Cell Renal Cell Carcinoma.
Autorzy:
Guo H; Department of Urology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan 250012, China.; Key Laboratory of Urinary Precision Diagnosis and Treatment in Universities of Shandong, Jinan, China.
Jiang S; Department of Urology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan 250012, China.; Key Laboratory of Urinary Precision Diagnosis and Treatment in Universities of Shandong, Jinan, China.
Sun H; Department of Urology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan 250012, China.; Key Laboratory of Urinary Precision Diagnosis and Treatment in Universities of Shandong, Jinan, China.
Shi B; Department of Urology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan 250012, China.; Key Laboratory of Urinary Precision Diagnosis and Treatment in Universities of Shandong, Jinan, China.
Li Y; Department of Urology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan 250012, China.; Key Laboratory of Urinary Precision Diagnosis and Treatment in Universities of Shandong, Jinan, China.
Zhou N; Department of Urology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan 250012, China.; Key Laboratory of Urinary Precision Diagnosis and Treatment in Universities of Shandong, Jinan, China.
Zhang D; Department of Urology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan 250012, China.; Key Laboratory of Urinary Precision Diagnosis and Treatment in Universities of Shandong, Jinan, China.
Guo H; Department of Urology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan 250012, China.; Key Laboratory of Urinary Precision Diagnosis and Treatment in Universities of Shandong, Jinan, China.
Pokaż więcej
Źródło:
Disease markers [Dis Markers] 2022 Mar 08; Vol. 2022, pp. 9443407. Date of Electronic Publication: 2022 Mar 08 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Prognosis*
Receptors, Interleukin*
Transcriptome*
Biomarkers, Tumor/*genetics
Carcinoma, Renal Cell/*genetics
Kidney Neoplasms/*genetics
Cell Line, Tumor ; Computational Biology ; Humans ; Survival Analysis ; Tumor Microenvironment ; Up-Regulation
Czasopismo naukowe
Tytuł:
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.
Autorzy:
Reig M; BCLC Group, Liver Unit, ICMDM, IDIBAPS, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain. Electronic address: .
Forner A; BCLC Group, Liver Unit, ICMDM, IDIBAPS, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain.
Rimola J; BCLC Group, Radiology Department, CDI, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Ferrer-Fàbrega J; BCLC Group, Surgery Department, ICMDM, IDIBAPS, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Burrel M; BCLC Group, Vascular Department, CDI, Hospital Clinic of Barcelona, Barcelona University, University of Barcelona, Barcelona, Spain.
Garcia-Criado Á; BCLC Group, Radiology Department, CDI, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Kelley RK; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
Galle PR; Department of Internal Medicine, Mainz University Medical Center, Mainz, Germany.
Mazzaferro V; Department of Oncology, University of Milan and HPB Surgery and Liver Transplantation, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Salem R; Department of Radiology, Section of Interventional Radiology, Northwestern University, Chicago, IL, USA.
Sangro B; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain; Liver Unit, Clinica Universidad de Navarra, Pamplona, Spain.
Singal AG; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Vogel A; Hannover Medical School, Department of Gastroenterology, Hepatology and Endocrinology, Hannover, Germany.
Fuster J; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain; BCLC Group, Surgery Department, ICMDM, IDIBAPS, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Ayuso C; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain; BCLC Group, Radiology Department, CDI, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Bruix J; BCLC Group, Liver Unit, ICMDM, IDIBAPS, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain. Electronic address: .
Pokaż więcej
Źródło:
Journal of hepatology [J Hepatol] 2022 Mar; Vol. 76 (3), pp. 681-693. Date of Electronic Publication: 2021 Nov 19.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Prognosis*
Carcinoma, Hepatocellular/*classification
Carcinoma, Hepatocellular/complications ; Female ; Humans ; Liver Neoplasms/classification ; Liver Neoplasms/complications ; Male ; Middle Aged ; Neoplasm Staging/methods ; Neoplasm Staging/statistics & numerical data ; Severity of Illness Index
Czasopismo naukowe
Tytuł:
Cell-Free DNA Variables including Gene Mutations in CA15-3 Normal Breast Cancer Reflect Prognosis.
Autorzy:
Xu J; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.; Department of Laboratory Medicine, Taizhou People's Hospital, Taizhou 225300, China.
Chen W; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Sun Z; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Peng H; Department of Laboratory Medicine, Taizhou People's Hospital, Taizhou 225300, China.
Zhou C; Department of Laboratory Medicine, Taizhou People's Hospital, Taizhou 225300, China.
Pan S; Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Pokaż więcej
Źródło:
Disease markers [Dis Markers] 2022 Feb 24; Vol. 2022, pp. 5470166. Date of Electronic Publication: 2022 Feb 24 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/pathology
Prognosis*
Cell-Free Nucleic Acids/*genetics
DNA Copy Number Variations/*genetics
Mutation/*genetics
Biomarkers, Tumor/genetics ; Female ; Humans ; Middle Aged ; Mucin-1
Czasopismo naukowe
Tytuł:
Comprehensive Analysis of Enhancer RNAs Identifies LINC00689 and ELFN1-AS1 as Novel Prognostic Biomarkers in Uveal Melanoma.
Autorzy:
Zhao S; Department of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.; School of Clinical Medicine, The Guizhou Medical University, Guiyang, Guizhou, China.
Jiang H; Department of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Liu J; Department of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Li DY; Department of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Li B; Department of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Long QR; Department of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Zheng L; Shenzhen Eye Hospital, Shenzhen, 5180403 Guangdong, China.
Gu H; Department of Ophthalmology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Pokaż więcej
Źródło:
Disease markers [Dis Markers] 2022 Feb 23; Vol. 2022, pp. 5994800. Date of Electronic Publication: 2022 Feb 23 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Disease-Free Survival*
Prognosis*
Enhancer Elements, Genetic/*genetics
Melanoma/*genetics
Uveal Neoplasms/*genetics
Biomarkers, Tumor/genetics ; Female ; Humans ; Male ; Nerve Tissue Proteins
SCR Disease Name:
Uveal melanoma
Czasopismo naukowe
Tytuł:
Integrated Analysis of DNA Repair Genes Identifies SLC6A1 as a New Marker for the Clinical Outcome of Patients with Colorectal Cancer.
Autorzy:
Wang QQ; School of Medicine, University of Electronic Science and Technology of China, Chengdu 611731, China.
Wei Y; Department of Medical Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan 610041, China.
Luo LP; Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan 610041, China.
Li X; Department of Medical Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan 610041, China.
Jiang WJ; Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan 610041, China.
Pokaż więcej
Źródło:
Disease markers [Dis Markers] 2022 Feb 22; Vol. 2022, pp. 4952812. Date of Electronic Publication: 2022 Feb 22 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
GABA Plasma Membrane Transport Proteins*
Prognosis*
Signal Transduction*
Survival Rate*
Colorectal Neoplasms/*genetics
DNA Repair/*genetics
Databases, Genetic/statistics & numerical data ; Down-Regulation ; Female ; Humans ; Male ; Phosphatidylinositol 3-Kinases/metabolism ; Up-Regulation
Czasopismo naukowe
Tytuł:
Identification and Validation of 7-lncRNA Signature of Epigenetic Disorders by Comprehensive Epigenetic Analysis.
Autorzy:
Cao P; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Qiaokou District, Wuhan City, Hubei Province, China 430030.
Li F; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Qiaokou District, Wuhan City, Hubei Province, China 430030.
Xiao Y; YuceBio Technology Co., Ltd., 4th Floor, Phase I, Dabaihui Center, No. 2002, Shenyan Road, Haishan Street, Yantian District, Shenzhen City, Guangdong Province, China 518000.
Hu S; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Qiaokou District, Wuhan City, Hubei Province, China 430030.
Kong K; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Qiaokou District, Wuhan City, Hubei Province, China 430030.
Han P; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Qiaokou District, Wuhan City, Hubei Province, China 430030.
Yue J; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Qiaokou District, Wuhan City, Hubei Province, China 430030.
Deng Y; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Qiaokou District, Wuhan City, Hubei Province, China 430030.
Zhao Z; YuceBio Technology Co., Ltd., 4th Floor, Phase I, Dabaihui Center, No. 2002, Shenyan Road, Haishan Street, Yantian District, Shenzhen City, Guangdong Province, China 518000.
Wu D; YuceBio Technology Co., Ltd., 4th Floor, Phase I, Dabaihui Center, No. 2002, Shenyan Road, Haishan Street, Yantian District, Shenzhen City, Guangdong Province, China 518000.
Zhang L; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jiefang Avenue, Wuhan, Hubei Province, China 430030.
Zhao B; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Qiaokou District, Wuhan City, Hubei Province, China 430030.
Pokaż więcej
Źródło:
Disease markers [Dis Markers] 2022 Feb 21; Vol. 2022, pp. 5118444. Date of Electronic Publication: 2022 Feb 21 (Print Publication: 2022).
Typ publikacji:
Journal Article; Validation Study
MeSH Terms:
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/mortality
Epigenesis, Genetic*
Lung Neoplasms*/genetics
Lung Neoplasms*/mortality
Prognosis*
Survival Rate*
RNA, Long Noncoding/*genetics
Female ; Gene Expression Profiling ; Humans ; Male ; Reproducibility of Results
Czasopismo naukowe
Tytuł:
Expression Profile and Prognostic Values of CDH Family Members in Lung Adenocarcinoma.
Autorzy:
Li F; Department of Oncology, The Chongqing Hospital of Traditional Chinese Medicine, Jiangbei District, Chongqing, China.
Wan B; Physical Examination Center, The Chongqing Hospital of Traditional Chinese Medicine, Jiangbei District, Chongqing, China.
Li XQ; Department of Oncology, The Chongqing Hospital of Traditional Chinese Medicine, Jiangbei District, Chongqing, China.
Pokaż więcej
Źródło:
Disease markers [Dis Markers] 2022 Feb 11; Vol. 2022, pp. 9644466. Date of Electronic Publication: 2022 Feb 11 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Prognosis*
Transcriptome*
Adenocarcinoma of Lung/*genetics
Biomarkers, Tumor/*genetics
Lung Neoplasms/*genetics
Cadherins ; Humans
Czasopismo naukowe
Tytuł:
Prognosis of Tumor Microenvironment in Luminal B-Type Breast Cancer.
Autorzy:
Lv J; Department of Surgery, The First Hospital of Qinhuangdao, Qinhuangdao City, Hebei Province, China.
Ren J; Department of Surgery, The First Hospital of Qinhuangdao, Qinhuangdao City, Hebei Province, China.
Zheng J; Department of Surgery, The First Hospital of Qinhuangdao, Qinhuangdao City, Hebei Province, China.
Zhang F; Department of Surgery, The First Hospital of Qinhuangdao, Qinhuangdao City, Hebei Province, China.
Han M; Department of Surgery, The First Hospital of Qinhuangdao, Qinhuangdao City, Hebei Province, China.
Pokaż więcej
Źródło:
Disease markers [Dis Markers] 2022 Feb 10; Vol. 2022, pp. 5621441. Date of Electronic Publication: 2022 Feb 10 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Databases, Genetic*
Gene Expression Profiling*
Prognosis*
Tumor Microenvironment*/genetics
Tumor Microenvironment*/immunology
Breast Neoplasms/*genetics
Aged ; Breast Neoplasms/immunology ; Breast Neoplasms/pathology ; Female ; Genes, p53 ; Humans ; Immunotherapy ; Middle Aged ; Mutation/genetics ; T-Lymphocytes/immunology
Czasopismo naukowe
Tytuł:
m6A-related lncRNAs predict prognosis and indicate immune microenvironment in acute myeloid leukemia.
Autorzy:
Zhong F; Jiangxi Province Key Laboratory of Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330006, Jiangxi, China.; School of Public Health, Nanchang University, No. 461 BaYi Boulevard, Nanchang, 330006, Jiangxi, China.
Yao F; Jiangxi Province Key Laboratory of Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330006, Jiangxi, China.
Cheng Y; Jiangxi Province Key Laboratory of Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330006, Jiangxi, China.
Liu J; Jiangxi Province Key Laboratory of Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330006, Jiangxi, China.
Zhang N; Jiangxi Province Key Laboratory of Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330006, Jiangxi, China.
Li S; Jiangxi Province Key Laboratory of Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330006, Jiangxi, China.
Li M; Jiangxi Province Key Laboratory of Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330006, Jiangxi, China.
Huang B; Jiangxi Province Key Laboratory of Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330006, Jiangxi, China. .; School of Public Health, Nanchang University, No. 461 BaYi Boulevard, Nanchang, 330006, Jiangxi, China. .
Wang X; Jiangxi Province Key Laboratory of Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330006, Jiangxi, China. .; School of Public Health, Nanchang University, No. 461 BaYi Boulevard, Nanchang, 330006, Jiangxi, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Feb 02; Vol. 12 (1), pp. 1759. Date of Electronic Publication: 2022 Feb 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/immunology
Leukemia, Myeloid, Acute*/pathology
Leukemia, Myeloid, Acute*/therapy
Prognosis*
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Computational Biology/methods ; Gene Expression Regulation, Neoplastic ; Gene Regulatory Networks ; Humans ; Immunotherapy ; Methyltransferases/metabolism ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Mitotic counts in one high power field in breast core biopsies is equivalent to counts in 10 high power fields.
Autorzy:
Lee W; Department of Pathology and Laboratory Medicine, University of California Irvine, CA, USA.
Law T; Department of Pathology and Laboratory Medicine, University of California Irvine, CA, USA.
Lu Y; Department of Population Health and Disease Prevention, Program in Public Health, University of California Irvine, CA, USA.
Lee TK; NeoGenomics Laboratories Inc., Aliso Viejo, CA, USA.
Ibarra JA; Department of Pathology and Laboratory Medicine, University of California Irvine, CA, USA; MemorialCare Orange Coast Medical Center, Fountain Valley, CA, USA. Electronic address: .
Pokaż więcej
Źródło:
Pathology [Pathology] 2022 Feb; Vol. 54 (1), pp. 43-48. Date of Electronic Publication: 2021 Dec 13.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/diagnosis
Breast Neoplasms*/pathology
Carcinoma, Ductal, Breast*/diagnosis
Carcinoma, Ductal, Breast*/pathology
Prognosis*
Biopsy, Large-Core Needle ; Breast/pathology ; Female ; Humans ; Mitosis ; Neoplasm Grading
Czasopismo naukowe
Tytuł:
A comparative study of AJCC and the modified staging system in pT2/pT3 penile squamous cell carcinoma - a validation on an external data set.
Autorzy:
Sali AP; Department of Pathology, Homi Bhabha Cancer Hospital (A Unit of Tata Memorial Centre), Sangrur, India.
Prakash G; Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
de Cássio Zequi S; Department of Urology, AC Camargo Cancer Center, São Paulo, Brazil.; National Institute for Science and Technology in Oncogenomics and Therapeutic Innovation. INCITO (CNPq/MCT/FAPESP/CAPES), São Paulo, Brazil.
da Costa WH; Department of Urology, AC Camargo Cancer Center, São Paulo, Brazil.
Murthy V; Department of Radiation Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
Soares FA; D'Or Institute for Research and Education (IDOR), São Paulo, Brazil.; Faculty of Dentistry, University of São Paulo, São Paulo, Brazil.
Bakshi G; Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
Guimarães GC; Department of Surgical Oncology, BP - A Beneficência Portuguesa de São Paulo, São Paulo, Brazil.
Joshi A; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
Pal M; Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
Desai SB; Department of Pathology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
Cubilla AL; Department of Pathology, Instituto de Patologia e Investigacion, Asuncion, Paraguay.
Menon S; Department of Pathology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2022 Feb; Vol. 80 (3), pp. 566-574. Date of Electronic Publication: 2021 Dec 28.
Typ publikacji:
Comparative Study; Journal Article; Validation Study
MeSH Terms:
Neoplasm Staging*
Prognosis*
Survival Analysis*
Carcinoma, Squamous Cell/*pathology
Penile Neoplasms/*pathology
Practice Guidelines as Topic/*standards
Aged ; Datasets as Topic ; Humans ; Male ; Middle Aged ; Retrospective Studies ; United States
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz